The historical rank and industry rank for Torrent Pharmaceuticals's Pretax Margin % or its related term are showing as below:
NSE:TORNTPHARM'
s Pretax Margin % Range Over the Past 10 Years
Min: 7.53 Med: 19.27 Max: 23.62
Current: 20.88
NSE:TORNTPHARM's Pretax Margin % is ranked better than 82.32% of 956
companies
in the Drug Manufacturers industry
Industry Median: 7.285
vs NSE:TORNTPHARM: 20.88
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Torrent Pharmaceuticals Pretax Margin % Related Terms
Torrent Pharmaceuticals Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TORNTPHARM vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Torrent Pharmaceuticals Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Torrent Pharmaceuticals's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a Pretax Margin % of 12.81% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Torrent Pharmaceuticals and its competitors. This is 34% below median its historical median of 19.27. Over the past decade, Torrent Pharmaceuticals' Pretax Margin % has ranged from 7.53 to 23.62. According to the industry distribution chart, Torrent Pharmaceuticals ranks #169 out of 956 companies in the Drug Manufacturers industry, placing it in the top 17.7%.
Is Torrent Pharmaceuticals' Pretax Margin % too high?
Torrent Pharmaceuticals' current Pretax Margin % of 12.81% is 34% below median its 10-year median of 19.27. Over the past 10 years, this metric has ranged from a low of 7.53 to a high of 23.62. The Drug Manufacturers industry median Pretax Margin % is 7.29. Torrent Pharmaceuticals' value of 12.81% is 75.8% above this industry median. Based on the distribution chart, Torrent Pharmaceuticals ranks #169 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Torrent Pharmaceuticals has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Torrent Pharmaceuticals ranks #169 out of 956 companies for Pretax Margin %. This places Torrent Pharmaceuticals in the top 18% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.29. Torrent Pharmaceuticals' value of 12.81% is 75.8% above this benchmark. Historically, Torrent Pharmaceuticals' own Pretax Margin % has ranged from 7.53 to 23.62 over the past decade. While the company's 10-year median is 19.27 vs. the industry median of 7.29, Torrent Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Torrent Pharmaceuticals's current Pretax Margin % of 12.81% is 75.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Torrent Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Torrent Pharmaceuticals's current Pretax Margin % is 12.81%, which is 34% below median its own 10-year median of 19.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹4,335.66, compared to a current price of ₹4,822.70 — trading 11.2% above its estimated fair value. The current Pretax Margin % is 12.81%, which is 34% below median its 10-year median of 19.27 and 75.8% above the Drug Manufacturers industry median of 7.29. Torrent Pharmaceuticals' overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current Pretax Margin % is 12.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹4,822.70 is trading 11.2% above its estimated GF Value™ of ₹4,335.66.
GuruFocus considers Torrent Pharmaceuticals to be Modestly Overvalued.
Key valuation signals for NSE:TORNTPHARM:
Pretax Margin %: 12.81% (34% below median its 10-year median of 19.27)
GF Value™: ₹4,335.66 vs. price of ₹4,822.70 (11.2% above fair value)
Industry Position: 75.8% above the Drug Manufacturers median (#169 of 956)
No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
87GF Score
Get the complete analysis for NSE:TORNTPHARM
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TORNTPHARM has been successfully added to your 
